Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Athersys Inc (NASDAQ:ATHX)

1.96
Delayed Data
As of Aug 25
 +0.02 / +1.03%
Today’s Change
0.94
Today|||52-Week Range
2.90
+90.29%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$166.6M

Company Description

Athersys, Inc. is a biopharmaceutical company which engages in the discovery and development of therapies designed to extend and enhance the quality of human life. Its product development program, MultiStem, a proprietary off the shelf stem cell product used to treat indications in the inflammatory & immune, neurological and cardiovascular disease areas. The Company was founded by John J. Harrington and Gil van Bokkelen on October 24, 1995 and is headquartered in Cleveland, OH.

Contact Information

Athersys, Inc.
3201 Carnegie Avenue
Cleveland Ohio 44115-2634
P:(216) 431-9900
Investor Relations:

Employees

Shareholders

Other institutional7.71%
Individual stakeholders10.94%
Mutual fund holders10.17%

Top Executives

Gil van BokkelenChairman & Chief Executive Officer
William B. J. LehmannPresident, Chief Operating Officer & Secretary
Laura K. CampbellPrincipal Accounting Officer & SVP-Finance
John J. HarringtonDirector, Chief Scientific Officer & Executive VP
Manal MorsyVice President & Head-Global Regulatory Affairs